A turning point for natural product discovery - ESF-EMBO research conference: synthetic biology of antibiotic production

Eriko Takano*, Roel A. L. Bovenberg, Rainer Breitling

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
373 Downloads (Pure)

Abstract

Synthetic Biology is in a critical phase of its development: it has finally reached the point where it can move from proof-of-principle studies to real-world applications. Secondary metabolite biosynthesis, especially the discovery and production of antibiotics, is a particularly relevant target area for such applications of synthetic biology. The first international conference to explore this subject was held in Spain in October 2011. In four sessions on General Synthetic Biology, Filamentous Fungal Systems, Actinomyces Systems, and Tools and Host Structures, scientists presented the most recent technological and scientific advances, and a final-day Forward Look Plenary Discussion identified future trends in the field.

Original languageEnglish
Pages (from-to)884-893
Number of pages10
JournalMolecular Microbiology
Volume83
Issue number5
DOIs
Publication statusPublished - Mar-2012

Keywords

  • SECONDARY METABOLISM
  • ESCHERICHIA-COLI
  • GENE-EXPRESSION
  • BIOSYNTHESIS
  • PATHWAY
  • RNA
  • GOADSPORIN
  • MICROBES
  • CLUSTERS
  • PROTEIN

Fingerprint

Dive into the research topics of 'A turning point for natural product discovery - ESF-EMBO research conference: synthetic biology of antibiotic production'. Together they form a unique fingerprint.

Cite this